chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dose 2 administered at 10 days.  Patient arrived after receiving text message from automated system to seek 2nd dose at 1130 am this date.  Vital Signs within normal limits.  No reaction noted at site or systemically at present.  Medical Director consulted.  Patient instructed to follow up with PCP or seek treatment in local ED if urgent needs develop.  Patient observed for 30 minutes.
headache all day; pins and needles all over parts of the body randomly. sometimes feet, hands, chest, armpit, dental; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache all day) and PARAESTHESIA (pins and needles all over parts of the body randomly. sometimes feet, hands, chest, armpit, dental) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced HEADACHE (headache all day) and PARAESTHESIA (pins and needles all over parts of the body randomly. sometimes feet, hands, chest, armpit, dental). At the time of the report, HEADACHE (headache all day) and PARAESTHESIA (pins and needles all over parts of the body randomly. sometimes feet, hands, chest, armpit, dental) outcome was unknown. Not Provided          Concomitant information use was not reported.  Treatment information was not provided.   This case was linked to MOD21-066614 (E2B Linked Report).; Sender's Comments:  MOD21-066614:MOD-2021-064127 -2nd Dose of Vaccine
Right arm swelling, with 7cm of erythema and induration T 100.9 developed about 18 hours post vaccine.
Fatigue Headache Lack of energy  sporadic fevers  ringing in the ears
FINGERS ON LEFT HAND HARD TO BEND (A LOT OF PAIN WHEN BENDING)
had both shots months before I got this terrible painful thing/suspected vaccination failure; got this terrible painful thing; terrible pain; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 7-Jun-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The patient had both Shingles shots months before patient got this terrible painful thing. The patient had Shingles 13 months ago. The patient still dealing with terrible pain.  Patient stated you did not want it, believe me. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding time to onset for target disease and laboratory confirmation were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
ADMINISTRATION ERROR : Pt. received a 3rd dose of Phizer 04/30/2021 after completing the 1st and 2nd (04/07/2021)
Severe pain upon injection of vaccine. The doctor apologized and said tetanus vaccine hurts because it?s intramuscular.  Immediate pain, stiffness of shoulder. Limited range of motion occurred next day.
Patient received immunization on 10/04/2023 for AREXVY and TWINRIX on her left arm and FluzoneHD on her right arm. Patient returned to the pharmacy on 10/05/2023 to report that she had a decent size of redness a round AREXVY injection site , no itching or warmth.
Mom noted listlessness & dark circles around eyes in am 2Jan, pt taken Hosp arrived @ 11am, found to have T 103, T escalating, pt died @ 1130 am, cause of death - dehydration, No fever noted @ time of Immun. to arrival @ hosp, no neuro S+S
Within 12 hours of shot, 100.9 fever.  24 hours after shot, 100.0 fever.
I received my second Pfizer booster for COVID-19 on 4/12/2022. On the evening of 6/30/2022, I had two itchy pustules on the left side of my spine that looked like chicken pox sores. The sores then started spreading. I've had them behind my left ear, on my left arm, on my left buttock, on my left thigh, behind my left knee, and on my left ankle. Then on 7/4/2022, I had one appear behind my right knee. So far, it's the only lesion that has appeared on the right side of my body. On 7/5/2022, I went to my PCP's office. The doctor diagnosed folliculitis and prescribed me doxycycline (100 mg, twice a day) and hydroxyzine (25 mg, four times a day). Before seeing the doctor, I had been  using OTC hydrocortisone cream in an effort to treat the sores, but it didn't help. The itching stopped by 7/7/2022, and the sores began to heal. At the time of this writing, I still have some of the sores, but they no longer itch, and they appear to be going away. With that being said, though, I did find a new one today on my left thigh. I put some hydrocortisone cream on it, which in conjunction with the antibiotics, seems to be helping it.
Rash in my armpit it's kind of magenta, look little creepy in the center section of it; it's not terribly irritating, it's a little irritating but doesn't really itch; This is a spontaneous report received from a contactable consumer (patient).  A 53-years-old male patient received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration in the left shoulder on 13Mar2021 (Lot Number: EN6207), at single dose for covid-19 immunisation. Medical history included allergy. Concomitant medications included vitamin C (ascorbic acid); vitamin D (unknown manufacturer); fexofenadine hydrochloride (ALLEGRA) taken for hypersensitivity, start and stop date were not reported. The patient experienced rash and skin irritation on 20Mar2021 with outcome of not recovered. It was reported that about a week after his first shot, the patient got a rash in his armpit it's kind of magenta, look little creepy in the center section of it. It's on the arm that he had the shot on. So, it was not terribly irritating, it was a little irritating but did not really itch. The patient guess he got the reaction to it. The patient was scheduled to receive the second dose on 10Apr2021.  No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a 4 year old male with hypersensitivity and atopy who on 29-JAN-2004 was vaccinated with a first dose of VARIVAX (Oka/Merck) (lot number, injection site and route not reported). On an unspecified date the patient was vaccinated with a second dose of VARIVAX (Oka/Merck) 0.5 ml by subcutaneous injection (injection site not reported). After the second dose, on 18-JUN-2008, the patient experienced an outbreak of the chickenpox. The patient's chickenpox persisted. Additional information has been requested.
On 6/9/2022 pt developed sudden chest pain. This was initially lower sub-sternal chest pain described as 5/10. Chest pain then became sharper and more severe in nature prompting a call to EMS. Pt was treated with aspirin en route to ED. Pain subsided within the next hour. There was no radiating pain, shortness of breath, nausea or diaphoresis. Pt had never experienced anything similar. EKG with without ischemic changes. Troponin at 3 hours was 13.9. Medication included ASA 324 mg, Plavix 75 mg and heparin bolus/drip. Pt transferred to higher level of care for admission per Cardiology where she underwent an ECHO and heart catheterization which demonstrated dissected coronary artery.
Client developed hives on cheeks, backs of hands and elbows about 24 hours, post vax.
Lt arm to wrist, neck, chest reddened x 1 hr. Denied itching. Took BENADRYL 25mg- Redness reduced over following 3 days until gone.
This case was reported by a physician and described the occurrence of fever in a patient who received DTAP, Hep B recombinant and IPV combined Pediarix for prophylaxis.  On an unspecified date, the patient received an injection of Pediarix.  On the same day, the patient also received an injection of HIB (PedvaxHIB, Merck).  At an unknown time post-immunication, the patient experienced fever of 101.3 degrees Fahrenheit. The outcome of the event was unknown.
GBS; pt hosp 10/13/99 to present;Annual follow-up dated 11/14/00 provided no additional data.
Sm developed a erythematous, macular-papular, mildly pruritic rash. Symptoms: Rash, Pruritic.
No adverse event; the patient was vaccinated with expired PROQUAD; Information has been received from a healthcare business professional who stated she was a nurse, referring to a female patient of unknown age. The patient's pertinent medical history, concurrent condition and concomitant therapy were not reported.         On 06-AUG-2019, the patient was vaccinated with expired measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # R002935, expiration date: 29-JUL-2019; strength, dose and route were not reported) for prophylaxis (expired product administered). The reporter stated that the vaccine did not have any temperature excursions prior to administration. No adverse symptoms reported.
patient fainted (syncope) for approx 5-10 seconds. Eyes rolled in back of head and was non-responsive. Kept patient from falling over and attempted to lie patient onto floor. She then woke up disoriented and confused. Had called 911 as a precaution. Patient refused treatment from EMTs said she felt sick to stomach and lightheaded. Symptoms resolved withing 5-10 minutes. Followed up with patient 2 hours later and she said she was having no further issues.
Extreme  fatigue, lightheaded and dizziness,  extreme joint pain, vision blurryness and sore eyes,  starting Wednesday March 3rd and continuing through today Monday, March 8th.   Also beginning Friday, March  5th woke up with right arm swollen just below the elbow.  Not sure if any of this is related to the Covid shot or having other problems. Just noticed that my vaccine card shows Lot #EN6202 but the letter sent says Lot #EL9263, for the 2nd dose.
27NOV96 pt recv vax & pt spiked a t104 & cont w/elevated temp until taken to ER 29NOV96;pt had rash behind ears;mom called on 2DEC96 no fever, rash on face;
Burning and tingling in my feet started 9/30. It progressed to my hands on 10/1. It feels like my feet and hands are asleep. It is still there as I make this report on 10/2. The paresthesia in my feet is worse than in my hands, but the tingling and burning feeling is constant and in unresponsive to acetaminophen. The burning in my feet has woken me through the night the last few nights. The exact same thing happened to me about a week after my 2nd Covid vaccine, which was also Pfizer and resolved about a week later. I did not experience this at all with my 3rd Covid shot, which is the only Moderna one that I've had.
This spontaneous report was received from a currently 79 female patient, concerning herself. The patient's historical drugs included an unspecified flu vaccine to which she was allergic. Concomitant drugs included about 14 unspecified medications. No information was provided regarding the patient's historical conditions. On an unknown date, the patient was vaccinated with pneumococcal  vaccine, polyvalent (manufacturer unknown) for prophylaxis (route of administration, lot number and expiration date were not provided). On unknown date, the patient started therapy with sitagliptin phosphate (JANUVIA) 100 mg tablets, once daily per via oral, (lot number an expiration date were not provided). In August 2016 (reported as "two years ago"), the patient was hospitalized due to an illness that she developed after receiving the  pneumococcal  vaccine, polyvalent (manufacturer unknown). On an unspecified date, the patient had side effects to sitagliptin phosphate (JANUVIA), even though it was effective for helping control her blood sugar. On an unknown date, the patient had a unspecified surgery, also since an unspecified date, the patient "does not see very well". On an unknown date, the patient experienced a flu. Therapy with sitagliptin phosphate (JANUVIA) was continued. At the time of the report, the patient still had the flu. The outcome of the remaining events was not provided. The patient considered the side effects to be related to therapy with sitagliptin phosphate (JANUVIA). The causal relationship between the remaining events and therapy with sitagliptin phosphate (JANUVIA) was not provided. The relationship between the events and therapy with the pneumococcal vaccine, polyvalent (manufacturer unknown) was not reported.
Tachycardia (Heart rate 134-160), flushing, reporting facial tingling. Resolved spontaneously after 45 minutes observation with no  interventions
Tingling down left arm, hand, into right arm, & hand, down both legs And rapid heartbeat. Occurred within 5 mins of getting vaccine, lasted A couple minutes.  Should I not get the 2nd vaccine?
Redness at the injection site; Swelling at the Injection site; This case was reported by a other health professional and described the occurrence of injection site erythema in a adolescent male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, less than a month after receiving Bexsero, the patient experienced injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site erythema and injection site swelling were recovered/resolved.   It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to Bexsero.  Additional details were provided as follows: This case was reported by the Medical Assistant (MA). The age at vaccination was not reported. Couple of weeks back from the date of reporting, the patient was administered of Bexsero and experience swelling and redness at the injection site that lasted 1.5 weeks.  The patient explained to her that the PI details a rate of localized adverse event at the injection site.
SHAKING; CHILLS; FEVER; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 16:30 for prophylactic vaccination.  The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced shaking, chills, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, fever and shaking was not reported. This report was non-serious. .
NO ENCOUNTERS OR TELEPHONE MESSAGES RECEIVED FROM PATIENT FAMILY. NO ADVERSE EVENTS, TREATMENTS, OR OUTCOMES CAN BE VERIFIED.
circumferential rash of left upper arm, evidently appearing on day of vaccination (2/25/21) with increased warmth, redness, induration, and itching; reportedly progressing through 2/28/21 with a sunburn-like appearance; continuing to improve to the date of follow-up with me (3/3/21) to darkening of the arm from the shoulder down to the elbow and mild residual itching. Pt treated the rash with oral Benadryl and topical hydrocortisone.
Adhesive Capsulitis of left shoulder. Rediness, swelling, stifness, extordinary pain, difficulty rotation used, not able to lift or used my arm to put my bra on, tyed my shoes, put my clothes on and off. Not be able to sleep and used my shoulder normally.
Patient has had 2 GTC seizures which started while sleeping, first one on 7/2/2021, seen in ER, ~1 hour post ictal period No treatment at that time. Second GTC seizure while sleeping on 7/16/2021, seen again in ER, similar post ictal period, started on Keppra.
Information has been received from a physician concerning a 16 year old female who in October 2007 (exact date unknown), was vaccinated (route and site not reported) with the 1st dose of Gardasil (lot # not reported). Three hours post vaccination, the patient passed out and was hospitalized. At the time of this report the patient was still in the hospital based on a cardiac related issue. The cardiologist states that the cardiac issue has nothing to do with the Gardasil the patient received. The physician felt that the patient's passing out and cardiac related issue were considered to be immediately life-threatening. Additional information has been requested.
17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml).    No concomitant medications were provided. No treatment medication was provided. This case contains information for the 15th of 17 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-707980 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-707980:Case for patient 1
RA red, warm to touch, hard under skin. Redness is 7 1/2 cm wide by 9 1/2 cm long.
Felt tingling of upper lip then lip began to swell. Saw personal physician who ordered Benadryl 50 mg.
3.5 hours after getting the shot, I had massive chills and accompanying shaking -- hand and arm movements of 6-12 inches. I had difficulty walking, being very clumsy, bumping into things, and having to use fixed objects (doorways...) to help guide myself. Was weak -- took multiple tries to get up from a recliner. There was also stiffness in the muscles. The injection site was only slightly tender. Temperature for 8pm-12M varied slightly around 103.6 degrees. When I went to bed at 3am it was down to 102.2 degrees. At 7am it was 101.8; at 1pm 99.6. At 24 hours after the shot, still stillness. I have had annual flu shots for as long as I can remember, and never had anything more than a mild reaction.  Reporting this because the rapid onset of symptoms and the severity could put people in danger if they are out-and-about.
Event occurred during COVID-19 vaccine clinic. Pt. 8 y/o was at the clinic for her 2nd dose of Pediatric Pfizer COVID-19 vaccine. Pt. received Moderna booster vaccine of 0.25 mg dose on left arm at 2:25pm. Moderna manufacturer was called at 3:55pm to report incident and collect information on the following error. Per Moderna representative, the guidance given was to notify pt. that no additional doses are needed and reference a study receiving moderna, which shows that adolescents are having similar side effects to the commonly reported side effects of headache, fever, pain at site, and fatigue.  Pt. was monitored for 30 mins for any adverse reactions.
Round puffy patch about 2.5" across with redness, itchiness, and heat.
received both Shingrix doses in 2018/broke out in Shingles in September 2020/for a second time/July 14, 2021/suspected Vaccination failure; broke out in Shingles in September 2020/ for a second time/July 14, 2021; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.  Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml and the 1st dose of Shingrix. On 14th July 2021, less than 2 years after receiving Shingrix and Shingrix, the patient experienced shingles. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant). The patient was treated with valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the vaccination failure and shingles were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were reported as follows: The reporter was the patient.   The patient received both Shingrix doses in 2018 on an unknown deltoid and broke out in Shingles in September 2020 along her waistline.   The patient was able to start taking Valtrex and the symptoms were resolved in 2 weeks and reported that the patient broke out in shingles for a second time which started a day before reporting on 14th July 2021. The symptoms continue and had not resolved.   The lot number and expiration dates for the vaccines were unknown.   The HCP contact information was provided and listed in call notes. The reporter consented to follow up.
I developed a headache and very mild difficulty concentrating about 16.5 hours after the injection.
Since receiving the J&J covid-19 vaccine, I have experienced severe joint pain in my hips, my knees, and sometimes ankles.  I have not contacted my Dr yet, but I am concerned about the joint pain not going away.  I also googled it and I saw that there are other people experiencing the same joint pain after the covid-19 vaccine.  Please let me know what to do.